Research method for promoting lymphoblast without tumorigenicity to be dedifferentiated in lactic acid/acid environment so as to obtain tumorigenicity
A B-lymphoblastoid and tumorigenic technology, applied in the direction of tumor/cancer cells, blood/immune system cells, biochemical equipment and methods, etc., can solve the problem of unclear lymphoma
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0037] Materials and methods
[0038] 2.1. Materials
[0039]Lactic acid was purchased from Sigma (Shanghai) Company. HMY2-CIR cell line was purchased from ATCC (Manassas, VA). RNase-free DNase I was purchased from Qiagen (Shanghai). TaqTM DNA polymerase was purchased from TaKaRa Biotechnology Co., Ltd. The RevertAidTM First Strand cDNA Synthesis Kit was purchased from Nanjing Novizan Company. Methocult H4230 methylcellulose was purchased from Stem Cell Technologies. PCR primers were ordered from Shanghai Sangon Biotechnology Co., Ltd.
[0040] 2.2. Cell culture
[0041] The culture medium of the HMY2-CIR cell line is 10% fetal calf serum, 100 U / ml penicillin and 100 μg / ml streptomycin added to DMEM high glucose medium, and adjusted to different pH values. The culture condition is 5% CO 2 , 37°C, the medium was changed every three days for eight weeks.
[0042] 2.3. Preparation of low pH medium
[0043] 20 mM lactic acid was dissolved in the above DMEM, the pH value ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com